OSE Immunotherapeutics SA (LON:0RAD)

OSE Immunotherapeutics Statistics

Total Valuation

LON:0RAD has a market cap or net worth of GBP 105.69 million. The enterprise value is 94.26 million.

Market Cap	105.69M
Enterprise Value	94.26M

Important Dates

The next estimated earnings date is Monday, December 29, 2025.

Earnings Date	Dec 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.42M
Shares Outstanding	n/a
Shares Change (YoY)	+31.11%
Shares Change (QoQ)	+3.65%
Owned by Insiders (%)	24.14%
Owned by Institutions (%)	1.97%
Float	16.21M

Valuation Ratios

The trailing PE ratio is 3.41 and the forward PE ratio is 6.06.

PE Ratio	3.41
Forward PE	6.06
PS Ratio	1.53
PB Ratio	2.00
P/TBV Ratio	2.01
P/FCF Ratio	2.64
P/OCF Ratio	2.64
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.40, with an EV/FCF ratio of 2.36.

EV / Earnings	3.04
EV / Sales	1.28
EV / EBITDA	2.40
EV / EBIT	2.45
EV / FCF	2.36

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.72.

Current Ratio	3.46
Quick Ratio	3.29
Debt / Equity	0.72
Debt / EBITDA	1.03
Debt / FCF	0.95
Interest Coverage	13.79

Financial Efficiency

Return on equity (ROE) is 86.29% and return on invested capital (ROIC) is 30.59%.

Return on Equity (ROE)	86.29%
Return on Assets (ROA)	26.54%
Return on Invested Capital (ROIC)	30.59%
Return on Capital Employed (ROCE)	42.16%
Revenue Per Employee	1.08M
Profits Per Employee	483,842
Employee Count	64
Asset Turnover	0.81
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0RAD has paid 1.97 million in taxes.

Income Tax	1.97M
Effective Tax Rate	5.99%

Stock Price Statistics

The stock price has decreased by -44.84% in the last 52 weeks. The beta is 0.96, so LON:0RAD's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-44.84%
50-Day Moving Average	6.16
200-Day Moving Average	6.15
Relative Strength Index (RSI)	33.96
Average Volume (20 Days)	760

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RAD had revenue of GBP 69.00 million and earned 30.97 million in profits. Earnings per share was 1.21.

Revenue	69.00M
Gross Profit	69.00M
Operating Income	36.17M
Pretax Income	32.94M
Net Income	30.97M
EBITDA	36.34M
EBIT	36.17M
Earnings Per Share (EPS)	1.21

Balance Sheet

The company has 48.89 million in cash and 38.15 million in debt, giving a net cash position of 10.74 million.

Cash & Cash Equivalents	48.89M
Total Debt	38.15M
Net Cash	10.74M
Net Cash Per Share	n/a
Equity (Book Value)	52.77M
Book Value Per Share	2.41
Working Capital	41.11M

Cash Flow

In the last 12 months, operating cash flow was 40.06 million and capital expenditures -63,677, giving a free cash flow of 39.99 million.

Operating Cash Flow	40.06M
Capital Expenditures	-63,677
Free Cash Flow	39.99M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 52.42% and 44.88%.

Gross Margin	100.00%
Operating Margin	52.42%
Pretax Margin	47.74%
Profit Margin	44.88%
EBITDA Margin	52.67%
EBIT Margin	52.42%
FCF Margin	57.96%

Dividends & Yields

LON:0RAD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.11%
Shareholder Yield	-31.11%
Earnings Yield	29.30%
FCF Yield	37.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RAD has an Altman Z-Score of 4.18 and a Piotroski F-Score of 6.

Altman Z-Score	4.18
Piotroski F-Score	6